Sun Pharmaceutical Industries Ltd.

Pharmaceuticals
India
Earnings Per Share Growth (%)24.34%
Cost of Goods Sold (US$ Millions)$1,017
Current Liabilities (US$ Millions)$2,473
Total Assets (US$ Millions)$4,403
Long Term Debt$207
Return on Equity24.50%
Revenue (US$ Millions)$4,231
Total Company Assets$7,413
Revenue Growth (%)68.23%
Net Income (US$ Millions)$686
Earnings Per Share (US$)$24.34
Total Equity (US$ Millions)$3,877
Profit Margin (%)16.22%
Debt To Equity Ratio (%)0.05%
Inventory Turnover$857